| EC | Endometrial cancer |
| PET/CT | Positron emission tomography/computed tomography |
| [18F]FDG | Fluorine-18–2-fluoro-2-deoxy-D-glucose |
| SUVmax | Maximum standardized uptake value |
| MTV | Metabolic tumor volume |
| TLG | Total lesion glycolysis |
| MRI | Magnetic resonance imaging |
| PET/MRI | Positron emission tomography/ magnetic resonance imaging |
| ESGO | European Society of Gynecological Oncology (ESGO) |
| ESTRO | European Society for Radiotherapy and Oncology |
| EANM | European Association of Nuclear Medicine |
| CRT | Chemoradiotherapy |
| SNMMI | Society of Nuclear Medicine and Molecular Imaging |
| [68Ga]-FAPI | [68Ga]-labeled fibroblast activation protein inhibitors |
| [18F]-4FMFES | 4-fluoro-11b-methoxy-16a-18 F-fluoroestradiol |
| [18F]-FES | 16a-18F-fluoro17b-estradiol |
| ERa | Estrogen receptor alpha |
| FIGO | International Federation of Gynecology and Obstetrics |
| OS | Overall survival |
| PPV | Positive predictive value |
| MI | Myometrial invasion |
| G | Grade |
| T | Tumor |
| N | Lymph node |
| M | Distant metastases |
| ML | Machine learning |
| DL | Deep learning |